Your browser doesn't support javascript.
loading
Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma.
Mirza, Abu-Sayeef; Kumar, Ambuj; Hashmi, Hamza; Garcia, Franco; Logothetis, Constantine N; Darwin, Alicia; Faramand, Rawan; Reid, Kayla; Bachmeier, Christina; Chavez, Julio C; Shah, Bijal; Pinilla-Ibarz, Javier; Khimani, Farhad; Lazaryan, Aleksandr; Liu, Hien; Davila, Marco L; Nishihori, Taiga; Locke, Frederick L; Jain, Michael D.
Afiliación
  • Mirza AS; Department of Internal Medicine, University of South Florida, Tampa, Florida.
  • Kumar A; University of South Florida Morsani College of Medicine, Tampa, Florida.
  • Hashmi H; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Garcia F; Department of Internal Medicine, University of South Florida, Tampa, Florida.
  • Logothetis CN; Department of Internal Medicine, University of South Florida, Tampa, Florida.
  • Darwin A; University of South Florida Morsani College of Medicine, Tampa, Florida.
  • Faramand R; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Reid K; Clinical Science Division, Moffitt Cancer Center, Tampa, Florida.
  • Bachmeier C; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Chavez JC; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida.
  • Shah B; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida.
  • Pinilla-Ibarz J; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida.
  • Khimani F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Lazaryan A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Liu H; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Davila ML; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida. Electronic address: Frederick.Locke@moffitt.org.
  • Jain MD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida. Electronic address: Michael.Jain@moffitt.org.
Transplant Cell Ther ; 27(3): 242.e1-242.e6, 2021 03.
Article en En | MEDLINE | ID: mdl-33781520
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Receptores Quiméricos de Antígenos Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Receptores Quiméricos de Antígenos Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article